Two‐year results of a low‐dose drug‐coated balloon for revascularization of the femoropopliteal artery: Outcomes from the ILLUMENATE first‐in‐human study

201591 citationsJournal Articlehybrid Open Access

Authors

The Stellarex DCB provides safe and durable clinical outcomes for treatment of femoropopliteal artery disease through 24 months.

Good health and well-being

Published in: Catheterization and Cardiovascular Interventions

Volume 86, Issue 2, pp. 278-286

Field-Weighted Citation Impact: 14.97